Nature Medicine

Papers
(The median citation count of Nature Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
SCOTUS v. reproductive health in United States1559
Rise in ambient temperature is associated with increased mortality in Latin America1463
Telemonitoring for complicated pregnancies1458
How virtual reality therapy is shaping mental health957
LLMs get a medical education789
Questionable role of new techniques in IVF embryo culture761
A genetic test to predict adverse drug reactions719
Easing the pain of endometriosis671
Liquid biopsies and tumor mutational burden: the cutoff conundrum640
A global metric of immune health622
Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology602
Solving medicine’s data bottleneck: Nightingale Open Science573
Recapitulating sensory feedback in artificial skin570
In vivo gene editing for inherited vision loss569
A fluid biomarker accurately detects tau aggregate pathology in Alzheimer’s disease566
First tumor-agnostic approval for an ADC519
Author Correction: Single-cell guided prenatal derivation of primary fetal epithelial organoids from human amniotic and tracheal fluids516
Not all KRAS-mutated pancreatic cancers are equal — mutant dosage matters491
Longitudinal analysis shows how microbiome changes might influence responses to immune checkpoint blockade476
Author Correction: Financial incentives for COVID-19 vaccines in a rural low-resource setting: a cluster-randomized trial467
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial449
An AI chatbot for talking therapy referrals438
Can an implanted minipump deliver for diabetes patients?424
The capacity of brain circuits to enhance psychiatry423
HIV prevention through PrEP in cisgender women421
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial417
Estimating the total effect of anthropogenic climate change on human health and wellbeing416
Promoting gender equity in the scientific and health workforce is essential to improve women’s health412
Combating vaccine revisionism411
HIPAA is a misunderstood and inadequate tool for protecting medical data409
Gene-edited pig liver successfully transplanted into human409
FDA approves first drug to delay type 1 diabetes405
The WHO genomics program of work for equitable implementation of human genomics for global health396
Estimating future heat-related and cold-related mortality under climate change, demographic and adaptation scenarios in 854 European cities393
Supported decision-making can advance clinical research participation for people with disabilities382
Changing climate and socioeconomic factors contribute to global antimicrobial resistance377
Anemia in women — an intractable problem that requires innovative solutions376
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes375
In utero origin of myelofibrosis presenting in adult monozygotic twins372
Author Correction: Digital consults in heart failure care: a randomized controlled trial365
The role of research in China’s successful elimination of malaria362
Concerns about the Burden of Proof studies360
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial358
PD-L1 and the dawn of modern cancer immunotherapy357
The inconvenient reality of AI-assisted embryo selection in IVF354
The uncertain science of preimplantation and prenatal genetic testing348
Targeted therapy for osteoarthritis: progress and pitfalls342
Integrating the environmental and genetic architectures of aging and mortality338
Author Correction: Unexplained post-acute infection syndromes334
An explainable foundation model for drug repurposing333
Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial330
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial327
Will ChatGPT transform healthcare?320
Continuous glucose monitoring and intrapersonal variability in fasting glucose320
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial320
The landscape of mRNA nanomedicine319
Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus319
Hippocampal network activity forecasts epileptic seizures314
Pregnant and lactating women should be included in clinical trials for cardiovascular disease311
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease308
Phenotypic signatures in clinical data enable systematic identification of patients for genetic testing303
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial299
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease297
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma297
Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial295
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial293
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy291
CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs291
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants289
Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality287
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial287
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial285
Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19283
AI as a new paradigm for risk-based screening for breast cancer281
Integrated image-based deep learning and language models for primary diabetes care280
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial280
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses277
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial272
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites269
WHO sets research agenda for refugee and migrant health267
Machine learning improves prediction of clinical outcomes for invasive breast cancers266
The Yearbook265
An anti-obesity drug from the diabetes toolbox263
An outdated loophole is letting faulty lab tests hit the market262
Rethinking aspirin for heart health260
High COVID-19 death toll in Africa260
Health in the Amazon259
The visible and hidden mortality caused by flooding257
Mapping the cellular landscape of the brain255
Acquired blood mutations cause acute kidney injury via dysregulated inflammation252
Familial confounding in the associations between maternal health and autism251
Anti-amyloid could help prevent genetic form of Alzheimer’s disease251
Steps to prevent and respond to an H5N1 epidemic in the USA250
Technology-assisted cognitive-behavioral therapy for perinatal depression delivered by lived-experience peers: a cluster-randomized noninferiority trial248
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates246
Microbiome–metabolome dynamics associated with impaired glucose control and responses to lifestyle changes246
Simulation-based estimates and projections of global, regional and country-level maternal mortality by cause, 1990–2050245
A benchmarking crisis in biomedical machine learning245
The expanding universe of checkpoint inhibitors for nasopharyngeal cancer244
Reply to Guyton, J. R. & Boden, W. E.; Schreiber, S. et al.242
Open Letter to G7 and G20 leaders: resolve global crises to secure our future240
From neoadjuvant to organ-sparing immunotherapy for colorectal cancer240
Coproducing health research with Indigenous peoples239
Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIV236
An African One Health network for antimicrobial resistance and neglected tropical diseases236
A gene-by-sex interaction contributes to liver disease susceptibility in women235
Health benefits of calorie restriction232
How patient advocates influence health policy231
Prenatal exposure to famine affects lifelong health231
siRNA therapy lowers triglycerides in patients with rare condition226
Meningioma risk stratification with a targeted gene-expression biomarker225
The effect of embryonic genome imbalances on pregnancy223
Menstrual health without stigma220
Using genetics to predict toxicity of cancer immunotherapy220
Brain pathology of COVID-19220
Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial219
Use of mobile diagnostics and digital clinical trials in cardiology219
Author Correction: Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury216
AI-generated text may have a role in evidence-based medicine213
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial212
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial210
Self-improving generative foundation model for synthetic medical image generation and clinical applications209
Multiomic analyses implicate a neurodevelopmental program in the pathogenesis of cerebral arachnoid cysts208
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection207
Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety207
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial205
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial205
Large-scale genome-wide association study of coronary artery disease in genetically diverse populations202
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy202
Clinical AI tools must convey predictive uncertainty for each individual patient200
The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans200
Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders196
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis196
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial195
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials194
Using unlabeled data to enhance fairness of medical AI193
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination193
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia193
A digital health algorithm to guide antibiotic prescription in pediatric outpatient care: a cluster randomized controlled trial192
Mpox continues to spread in Africa and threatens global health security192
Smartwatch- and smartphone-based remote assessment of brain health and detection of mild cognitive impairment192
Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection191
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother–child pairs190
Determinants of COVID-19 vaccination status and hesitancy among older adults in China190
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity189
The limits of fair medical imaging AI in real-world generalization188
Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial188
Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults187
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure186
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial186
Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer186
Genome-wide polygenic score to predict chronic kidney disease across ancestries186
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer185
Emerging diagnostics and therapeutics for Alzheimer disease185
Advancing global antibiotic research, development and access184
An integrated cell atlas of the lung in health and disease183
Gene therapy for alcohol-use disorder182
Could video games be good for your health?181
Pig-to-human transplants inch closer to reality179
ALS therapy hits molecular mark but misses clinical one179
A human brain circuit for addiction remission177
A smart solution for detecting ear problems175
A pinch of salt for heart disease175
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial175
Challenges with benchmarking of MDMA-assisted psychotherapy174
The impact of school opening model on SARS-CoV-2 community incidence and mortality172
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial170
Deciphering the heritability of human height170
The unseen climate health risks of antimicrobial resistance in urban informal settlements170
Targeted radiation adds precision to cancer therapy169
Author Correction: T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection169
A framework to assess the effects of genetic risk factors on disability-adjusted life years167
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma167
Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery166
Human embryo models offer glimpse into early development166
Gene-editing breakthrough for a rare hereditary disorder165
Using implementation science to navigate the complexity of integrating genomics into healthcare164
Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers164
New neurons are born in the adult human brain163
Imatinib and the dawn of precision cancer therapy163
COVID-19 vaccination gives hope to eradicate polio162
Countering the impact of the climate crisis on health will require data162
Adequate information about clinical trial results must be given to participants162
Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis161
Author Correction: The impact of school opening model on SARS-CoV-2 community incidence and mortality161
Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants159
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial159
Why paying individual people for their health data is a bad idea158
Hibernation science harnessed to treat obesity and modify metabolism158
Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year158
Escitalopram for agitation in Alzheimer’s dementia: a randomized controlled phase 3 trial156
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial155
The VolREthics initiative to protect the well-being of healthy volunteers in biomedical research154
A federated learning system for precision oncology in Europe: DigiONE153
Advancing clinical genomics with Middle Eastern and South Asian pangenomes152
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma151
Multi-ancestry polygenic mechanisms of type 2 diabetes147
A neural stem-cell treatment for progressive multiple sclerosis145
Determinants and inequities in healthy working life expectancy in China145
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial145
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma145
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster144
Reduction in life expectancy in Brazil after COVID-19143
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination142
City-level impact of extreme temperatures and mortality in Latin America142
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans141
A H3K27M-targeted vaccine in adults with diffuse midline glioma141
Integrating liver endpoints in clinical trials of cardiovascular and kidney disease140
Cities, communities and clinics can be testbeds for human exposome and aging research139
Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics138
Caution at psychiatry’s psychedelic frontier138
AI-guided precision parenteral nutrition for neonatal intensive care units138
Single-nucleus chromatin accessibility and transcriptomic map of breast tissues of women of diverse genetic ancestry138
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination137
Bacterial SNPs in the human gut microbiome associate with host BMI134
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases133
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution133
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial132
CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial132
AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial132
The economic value of reducing avoidable mortality130
The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology130
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial130
Differential peripheral immune signatures elicited by vegan versus ketogenic diets in humans130
Mapping the mediators of Alzheimer’s disease129
Targeting KRAS in cancer129
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine129
Boosting the efficacy of emergency contraception128
Modeling multiple myeloma heterogeneity in mice to advance therapeutic discoveries128
‘Inverse vaccines’ could treat autoimmune disease — from multiple sclerosis to celiac disease128
Balancing the risks of HIV transmission at low viral load128
Tumor infiltrating lymphocyte approval heralds new era for precision cancer immunotherapy128
11 clinical trials that will shape medicine in 2022127
The role of placebo control in clinical trials for neurodegenerative diseases127
Blood lipid profiling indicates that dietary fat quality is associated with cardiometabolic risk126
Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality126
Large floods drive changes in cause-specific mortality in the United States126
Publisher Correction: Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis126
Pakistan is failing in maternal and neonatal tetanus elimination125
Facilitating limb movement after stroke124
Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases124
Building resilience in heatwaves124
Improving scientific integrity in Chinese medical institutions with the Hospital Research Integrity Alliance123
Evolution, genetic diversity, and health123
Author Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers122
Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression121
Personalized lab test models to quantify disease potentials in healthy individuals119
Emergence of measles during the COVID-19 pandemic threatens Pakistan’s children and the wider region119
Clinical trial design during and beyond the pandemic: the I-SPY COVID trial118
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease118
0.20979809761047